OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0694-AI84 View EO 12866 Meetings | Received Date: 08/01/2022 |
| Title: Request for Comments Concerning the Imposition of Emerging Technology Export Controls on Instruments for the Automated Chemical Synthesis of Peptides | |
| Agency/Subagency: DOC / BIS | Stage: Prerule |
| Concluded Action: Consistent with Change | Concluded Date: 08/26/2022 |
| Legal Deadline: None | Economically Significant: No |
| Publication Date: | Unfunded Mandates: No |
| Major: No | Related To Homeland Security: Yes |
| Regulatory Flexibility Analysis Required: No | Small Entities Affected: No |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: Yes | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: No | |
An official website of the United States government



